Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial*

Abstract

Infusion of h-ANP at a rate of 50 ng.kg(-1).min(-1) enhances renal excretory function, decreases the probability of dialysis, and improves dialysis-free survival in early, ischemic acute renal dysfunction after complicated cardiac surgery.